Cotecna's Cutting-Edge Mumbai Lab Boosts India's Pharma Testing Capabilities

Cotecna Life Sciences India has unveiled a state-of-the-art laboratory in Mumbai, marking a significant advancement in India's pharmaceutical testing landscape. The FDA-approved and NABL-accredited facility, equipped with cutting-edge technology, aims to accelerate drug development and ensure regulatory compliance. Sebastien Dannaud, CEO at Cotecna Inspection, emphasized the lab's role in supporting India's pharmaceutical sector and driving innovation. By combining advanced technology with expertise from its global network, including SHIVA Labs in India and Neotron Pharma in Europe, Cotecna is poised to deliver comprehensive solutions such as impurity analysis, stability studies, and pharmacopeial testing, meeting the highest international standards.

 

Sources: ANI, Cotecna official website